header
banner


Home
Efficacy
Safety and Tolerability
Treatment Guidelines
Clinical News
Quality
Understanding Isoflavones
Mechanism of Action: SERM
Pharmacokinetics of Promensil
Epidemiology of Isoflavone Intake
Go to Full Reference List
Request a Reprint
Promensil Product Range
Order a Sample Pack
Contact us

Site & Blog Search

Search Site Search Blog

Go Back to Consumer Site

bar

Mechanism of action: SERM

figure 1
__Figure 1. Schematic showing interaction of isoflavones and
__the human oestrogen receptor (adated from reference 60)

The estrogenic activity of isoflavones is relatively weak, of the order of 1000 times less than that of 17ß-estradiol. However, when consumed in relatively large amounts, plasma levels of isoflavone active metabolites are significant 23,24. Before menopause when endogenous estrogen levels are high, isoflavones may exert anti-estrogenic activity by competitive inhibition, preventing estrogen from binding to the estrogen receptor. During and after menopause when endogenous estrogens decline isoflavones produce a surrogate estrogen effect.

Isoflavones and their metabolites can preferentially activate the form of the estrogen receptor which predominates in brain, bone and heart (ER-ß) but show little activity against the form of estrogen receptor present in breast and uterine tissues (ER-α) 25 (Table 2). Isoflavones do not bind or activate the androgen receptor. 26

figure 2
__Figure 2. ER-α and ER-ß receptors predominate in various tissues

Compound Relative Binding Affinity
  ER-α ER-ß
17ß-estradiol 100 100
2-OH-estrone 2 0.2
5-androstenediol 1 7
4-OH-tamoxifen 257 232
Raloxifene 69 16
Isoflavones
Genistein
Daidzein

4
0.1

87
0.5
Table 2. Relative binding affinity of compounds to ER-α and ER-ß

References
Collins BM, McLachlan JA, and Arnold SF.23 Steroids 1997; 62 (4): 365-72. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast.
Miksicek RJ. 24 Proc Soc Exp Biol Med 1995; 208: 44-50. Estrogenic flavonoids: Structural requirements for biological activity.
Couse JF, Lindzey J, Grandien K, Gustafsson JA, and Korach KS. 25 Endocrinol 1997; 138 (11): 4613-21. Tissue distribution and quantitative analysis of estrogen receptor-alpha and estrogen receptor-beta messenger ribonucleic acid in the wild-type and ER-alpha knockout mouse.
Cato AC, Miksicek R, Schütz G, Arnemann J, and Beato M. 26 Embo J 1986; 5 (9): 2237-40. The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction.
Adlercreutz H. 60 Bailliere’s Clin. Endocrinol. Metab. 1998; 12:605-625. Epidemiology of Phytoestrogens

» Go to Full Reference List